Researchers find potential to make brain cancers in children respond better to treatment. – Brinkwire

Brain cancer in children is always a devastating diagnosis, but McMaster University researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.
Medulloblastoma (MB) is the most common malignant childhood brain tumor and it has recently been categorized into four molecular subtypes. Group 1 tumors have excellent outcomes, rarely spread, and are rarely lethal. But Groups 2, 3 and 4 are still aggressive, have metastatic spread and are leth…

Click here to view the original article.